This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Università Degli Studi Di Roma "La Sapienza", Universitá Degli Studi Di Siena. Active years: 2018.
Company Filing History:
1 out of 63 
1 out of 18 Years Active: 2018
Title: Romina Alfonsi: Innovator in Hedgehog Pathway Inhibition
Introduction
Romina Alfonsi is a distinguished inventor based in Rome, Italy. She has made significant contributions to the field of biomedical research, particularly in the development of compounds that target the Hedgehog signaling pathway. Her work is crucial for advancing treatments for Hh-dependent tumors.
Latest Patents
Romina holds a patent for "Multitarget hedgehog pathway inhibitors and uses thereof." This invention focuses on compounds that selectively inhibit the activity of the Hedgehog (Hh) pathway. The compounds are particularly useful in treating Hh-dependent tumors, such as medulloblastoma (MB). She has been recognized for her innovative approach to addressing complex medical challenges.
Career Highlights
Throughout her career, Romina has been associated with prestigious institutions, including Università Degli Studi Di Roma "La Sapienza" and Università Degli Studi Di Siena. Her academic background and research experience have positioned her as a leading figure in her field.
Collaborations
Romina has collaborated with notable colleagues, including Bruno Botta and Alberto Gulino. These partnerships have enhanced her research and contributed to the advancement of her innovative projects.
Conclusion
Romina Alfonsi's work in the field of Hedgehog pathway inhibitors exemplifies her commitment to innovation and medical advancement. Her contributions are paving the way for new treatments for serious health conditions.